TPN-729-MA
N/A
Report date: 2025/11/25 15:52:33
NME
Base Information
Drug NameTPN-729-MA
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesTopharman Shanghai Co LtdShandong Tefaman Pharmaceutical Co LtdShanghai Institute Of Materia Medica, Chinese Academy Of Sciences +[4]
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesShandong Tefaman Pharmaceutical Co LtdTopfond Pharmaceutical Co LtdShanghai Institute Of Materia Medica, Chinese Academy Of Sciences +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A